Paroxetine hydrochloride - Italfarmaco

Drug Profile

Paroxetine hydrochloride - Italfarmaco

Alternative Names: Dropax; Dropaxin; Paroxetine - Italfarmaco; Paroxetine betaciclodextrin; Paroxetine hydrochloride; Serestill

Latest Information Update: 31 May 2012

Price : $50

At a glance

  • Originator Italfarmaco
  • Class Antidepressants; Anxiolytics; Benzodioxoles; Fluorobenzenes; Irritable bowel syndrome therapies; Piperidines; Small molecules
  • Mechanism of Action Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Generalised anxiety disorder; Major depressive disorder; Obsessive-compulsive disorders; Panic disorder; Post-traumatic stress disorders; Social phobia

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 17 Dec 2007 Dropaxin® launched for Generalised anxiety disorder in Italy during 2006 (PO)
  • 17 Dec 2007 Dropaxin® launched for Major depressive disorder in Italy during 2006 (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top